Protection of pancreatic β-cells by exendin-4 may involve the reduction of endoplasmic reticulum stress; in vivo and in vitro studies

Journal of Endocrinology

Volumn 193, Issue 1, 2007, Pages 65-74

  Tsunekawa, Shin ^c   Yamamoto, Naoki ^c   Tsukamoto, Katsura ^a   Itoh, Yuji ^b   Kaneko, Yukiko ^b   Kimura, Toshihide ^b   Ariyoshi, Yoh ^c   Miura, Yoshitaka ^c   Oiso, Yutaka ^c   Niki, Ichiro ^b  

^a SANWA KAGAKU KENKYUSHO CO LTD   (Japan)

^b OITA UNIVERSITY   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 4; CALMODULIN; EXENDIN 4; GROWTH ARREST AND DNA DAMAGE INDUCIBLE PROTEIN 153; IMMUNOGLOBULIN BINDING FACTOR; INOSITOL; INOSITOL REQUIRING ENZYME 1 ALPHA; INSULIN; PROTEIN KINASE; RNA ACTIVATED PROTEIN KINASE LIKE ENDOPLASMIC RETICULUM KINASE; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; CELL DEATH; CELL PROTECTION; CELL STRESS; CONTROLLED STUDY; DRUG EFFECT; ENDOPLASMIC RETICULUM; FEMALE; GENE EXPRESSION; HYPERGLYCEMIA; HYPERPHAGIA; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PANCREAS ISLET BETA CELL; POLYURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CALMODULIN; DIABETES MELLITUS; ENDOPLASMIC RETICULUM; HEAT-SHOCK PROTEINS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN-SECRETING CELLS; MICE; MICE, TRANSGENIC; MOLECULAR CHAPERONES; PEPTIDES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STRESS; TRANSCRIPTION FACTOR CHOP; VENOMS;

EID: 34247340606     PISSN: 00220795     EISSN: None     Source Type: Journal    
DOI: 10.1677/JOE-06-0148     Document Type: Article

References (39)

1. Bregenholt S, Moldrup A, Blume N, Karlsen AE, Nissen Friedrichsen B, Tornhave D, Knudsen LB & Petersen JS 2005 The long-acting glucagon-like peptide-1 analogue, liraglutide, inhibits beta-cell apoptosis in vitro. Biochemical and Biophysical Research Communications 330 577-584.
2. Butler AE, Janson J, Bonner-Weir S, Ritzel R, Rizza RA & Butler PC 2003 Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes. Diabetes 52 102-110.
3. 2+, leading to induction of endoplasmic reticulum stress in pancreatic beta-cells. Diabetes 54 452-461.
4. Dardevet D, Moore MC, Neal D, DiCostanzo CA, Snead W & Cherrington AD 2004 Insulin-independent effects of GLP-1 on canine liver glucose metabolism: duration of infusion and involvement of hepatoportal region. American Journal of Physiology, Endocrinology and Metabolism 287 E75-E81.
5. Donath MY, Gross DJ, Cerasi E & Kaiser N 1999 Hyperglycemia-induced beta-cell apoptosis in pancreatic islets of Psammomys obesus during development of diabetes. Diabetes 48 738-744.
6. Drucker DJ 2003 Glucagon-like peptides: regulators of cell proliferation, differentiation, and apoptosis. Molecular Endocrinology 17 161-171.
7. 2+ concentration. Journal of Biological Chemistry 273 33501-33507.
8. Egan JM, Montrose-Rafizadeh C, Wang Y, Bernier M & Roth J 1994 Glucagon-like peptide-1(7-36) amide (GLP-1) enhances insulin-stimulated glucose metabolism in 3T3-L1 adipocytes: one of several potential extrapancreatic sites of GLP-1 action. Endocrinology 135 2070-2075.
9. Eng J, Kleinman WA, Singh L, Singh G & Raufman JP 1992 Isolation and characterization of exendin-4, an exendin-3 analogue, from Heloderma suspectum venom. Further evidence for an exendin receptor on dispersed acini from guinea pig pancreas. Journal of Biological Chemistry 267 7402-7405.
10. Epstein PN, Overbeek PA & Means AR 1989 Calmodulin-induced early-onset diabetes in transgenic mice. Cell 58 1067-1073.
11. Gedulin BR, Nikoulina SE, Smith PA, Gedulin G, Nielsen LL, Baron AD, Parkes DG & Young AA 2005 Exenatide (exendin-4) improves insulin sensitivity and β-cell mass in insulin-resistant obese fa/fa Zucker rats independent of glycemia and body weight. Endocrinology 146 2069-2076.
12. Gromada J, Ding WG, Barg S, Renstrom E & Rorsman P 1997 Multisite regulation of insulin secretion by cAMP-increasing agonists: evidence that glucagon-hke peptide 1 and glucagon act via distinct receptors. Pflugers Archiv 434 515-524.
13. Harding HP & Ron D 2002 Endoplasmic reticulum stress and the development of diabetes: a review. Diabetes 51 (Suppl 3) S455-S461.
14. Harrison LC, Campbell IL, Allison J & Miller JF 1989 Mechanisms of pancreatic β-cell destruction: immune and nonimmune. In Perspectives on the Molecular Biology and Immunology of the Pancreatic β Cell, pp 93-102. Eds D Hanahan, HO McDevitt & GF Cahill. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory.
15. Jhala US, Canettieri G, Screaton RA, Kulkarni RN, Krajewski S, Reed J, Walker J, Lin X, White M & Montminy M 2003 cAMP promotes pancreatic beta-cell survival via CREB-mediated induction of IRS2. Genes and Development 17 1575-1580.
16. 2+ release in INS-1 pancreatic beta cells. Journal of Physiology 546 175-189.
17. 2+-ATPase (SERCA)-2b and -3. Diabetes 53 1517-1525.
18. Leon DD, Crutchlow MF, Ham JY & Stoffers DA 2005 Role of glucagon-like peptide-1 in the pathogenesis and treatment of diabetes mellitus. International Journal of Biochemistry and Cell Biology 38 845-859.
19. Luque MA, Gonzalez N, Marquez L, Acitores A, Redondo A, Morales M, Valverde I & Villanueva-Penacarrillo ML 2002 Glucagon-like peptide-1 (GLP-1) and glucose metabolism in human myocytes. Journal of Endocrinology 173 465-473.
20. Mandrup-Poulsen T 2003 Apoptotic signal transduction pathways in diabetes. Biochemical Pharmacology 66 1433-1440.
21. Montrose-Rafizadeh C, Avdonin P, Garant MJ, Rodgers BD, Kole S, Yang H, Levine MA, Schwindinger W & Bernier M 1999 Pancreatic glucagon-like peptide-1 receptor couples to multiple G proteins and activates mitogen-activated protein kinase pathways in Chinese hamster ovary cells. Endocrinology 140 1132-1140.
22. Oyadomari S, Araki E & Mori M 2002 a Endoplasmic reticulum stress-mediated apoptosis in pancreatic beta-cells. Apoptosis 7 335-345.
23. Oyadomari S, Koizumi A, Takeda K, Gotoh T, Akira S, Araki E & Mori M 2002 b Targeted disruption of the Chop gene delays endoplasmic reticulum stress-mediated diabetes. Journal of Clinical Investigation 109 525-532.
24. Park S, Dong X, Fisher TL, Dunn S, Omer AK, Weir G & White MF 2006 Exendin-4 uses Irs2 signaling to mediate pancreatic beta cell growth and function. Journal of Biological Chemistry 281 1159-1168.
25. 2+ sequestration in diabetic mouse islets of Langerhans. Journal of Biological Chemistry 269 18279-18282.
26. Scheuner D, Mierde DV, Song B, Flamez D, Creemers JW, Tsukamoto K, Ribick M, Schuit FC & Kaufinan RJ 2005 Control of mRNA translation preserves endoplasmic reticulum function in beta cells and maintains glucose homeostasis. Nature Medicine 11 757-764.
27. Schildberg FA, Schulz S, Dombrowski F & Minor T 2005 Cyclic AMP alleviates endoplasmic stress and programmed cell death induced by lipopolysaccharides in human endothelial cells. Cell and Tissue Research 320 91-98.
28. Sugden MC, Christie MR & Ashcroft SJ 1979 Presence and possible role of calcium-dependent regulator (calmodulin) in rat islets of Langerhans. FEBS Letters 105 95-100.
29. Thorens B 1992 Expression cloning of the pancreatic beta cell receptor for the gluco-incretin hormone glucagon-like peptide 1. PNAS 89 8641-8645.
30. Tsunekawa S, Miura Y, Yamamoto N, Itoh Y, Ariyoshi Y, Senda T, Oiso Y & Niki I 2005 Systemic administration of pituitary adenylate cyclase-activating polypeptide maintains beta-cell mass and retards onset of hyperglycaemia in beta-cell-specific calmodulin-overexpressing transgenic mice. European Journal of Endocrinology 152 805-811.
31. Valverde I & Malaisse WJ 1984 Calmodulin and pancreatic B-cell function. Experientia 40 1061-1068.
32. 2+-ATPase are differentially expressed in normal and diabetic islets of Langerhans. Biochemical Journal 319 521-527.
33. 2+-transport ATPase 3 gene (SERCA3) in Caucasian type II diabetic patients (UK Prospective Diabetes Study 48). Diabetologia 42 1240-1243.
34. Wang Q & Brubaker PL 2002 Glucagon-like peptide-1 treatment delays the onset of diabetes in 8 week-old db/db mice. Diabetologia 45 1263-1273.
35. 2+]i-reducing action of cAMP in rat pancreatic beta-cells: involvement of thapsigargin-sensitive stores. American Journal of Physiology 274 C513-C521.
36. +. Annals of the New York Academy of Sciences 865 445-450.
37. 2+-dependent apoptosis of pancreatic beta cells, which can be prevented by inhibition of nitric oxide synthase. Laboratory Investigation 82 1229-1239.
38. Yusta B, Baggio LL, Estall JL, Koehler JA, Holland DP, Li H, Pipeleers D, Ling Z & Drucker DJ 2006 GLP-1 receptor activation improves beta cell function and survival following induction of endoplasmic reticulum stress. Cell Metabolism 4 391-406.
39. 2+ stores and arachidonic acid metabolism. Journal of Clinical Investigation 101 1623-1632.